Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma

Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression

(2015) T.-S. Chang et al.   CLINICAL CANCER RESEARCH

Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism

(2015) Peter Csermely et al.   SEMINARS IN CANCER BIOLOGY

Cancer Stem Cells: The Promise and the Potential

(2015) Jaffer A. Ajani et al.   SEMINARS IN ONCOLOGY

Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis

(2014) Han-Chieh Wu et al.   HUMAN PATHOLOGY

New Methods in Tissue Engineering: Improved Models for Viral Infection

(2014) Vyas Ramanan et al.   Annual Review of Virology

Inflammation and cancer stem cells

(2013) Sarah Shigdar et al.   CANCER LETTERS

Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling

(2013) Guobin He et al.   CELL

Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009

(2013) Arndt Weinmann et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

(2012) Juanjuan Shan et al.   HEPATOLOGY

Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection

(2011) Ning Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

(2011) M. Jinushi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development and Maintenance of Cancer Stem Cells under Chronic Inflammation

(2011) Toshihiko Tanno et al.   JOURNAL OF NIPPON MEDICAL SCHOOL

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

(2010) Xiao Qi Wang et al.   HEPATOLOGY

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage

(2010) Victoria Tovar et al.   JOURNAL OF HEPATOLOGY

The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets

(2010) Ju Dong Yang et al.   SEMINARS IN CANCER BIOLOGY

Inflammation and Liver Cancer

(2009) C. Berasain et al.   Annals of the New York Academy of Sciences

Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis

(2009) Matteo Cescon   ARCHIVES OF SURGERY

Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma

(2009) C. Desbois-Mouthon et al.   CLINICAL CANCER RESEARCH

Pluripotency of mouse spermatogonial stem cells maintained by IGF-1- dependent pathway

(2009) Yen-Hua Huang et al.   FASEB JOURNAL

Liver Cancer Stem Cells

(2008) Stewart Sell et al.   JOURNAL OF CLINICAL ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE